Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV Subcutaneously
Clinical trial NCT00782106 · COMPLETED
Trial details
- NCT number
- NCT00782106
- Sponsor
- Baxalta now part of Shire
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-04
- Primary completion
- 2007-11-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.